رجوع
نطاق اليوم
KWD 45.71
KWD 47.17
نطاق 52 أسبوعًا
KWD 18.26
KWD 49.12
حجم التداول
623,032
متوسط 50 يوم / 200 يوم
KWD 44.22
/
KWD 37.72
الإغلاق السابق
KWD 46.08
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 57.9 | 0.4 |
| P/B | 6.0 | 2.9 |
| ROE % | 11.7 | 3.7 |
| Net Margin % | 8.7 | 3.8 |
| Rev Growth 5Y % | 104.8 | 10.0 |
| D/E | 0.0 | 0.2 |
النقاط الرئيسية
Revenue grew 104.76% annually over 5 years — strong growth
ROE of 11.73% — decent returns on equity
Debt/Equity of 0.02 — conservative balance sheet
Generating 25.41M in free cash flow
P/E of 57.90 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 44.67%
النمو
Revenue Growth (5Y)
104.76%
Revenue (1Y)60.09%
Earnings (1Y)N/A
FCF Growth (3Y)38.90%
الجودة
Return on Equity
11.73%
ROIC10.04%
Net Margin8.71%
Op. Margin11.40%
الأمان
Debt / Equity
0.02
Current Ratio3.79
Interest Coverage0.00
التقييم
P/E Ratio
57.90
P/B Ratio6.02
EV/EBITDA42.22
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 60.09% | Revenue Growth (3Y) | 58.34% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 104.68% |
| Revenue Growth (5Y) | 104.76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 677.56M | Net Income (TTM) | 59.01M |
| ROE | 11.73% | ROA | 7.73% |
| Gross Margin | 54.63% | Operating Margin | 11.40% |
| Net Margin | 8.71% | Free Cash Flow (TTM) | 25.41M |
| ROIC | 10.04% | FCF Growth (3Y) | 38.90% |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 3.79 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 57.90 | P/B Ratio | 6.02 |
| P/S Ratio | 5.04 | PEG Ratio | -0.22 |
| EV/EBITDA | 42.22 | Dividend Yield | 0.00% |
| Market Cap | 3.42B | Enterprise Value | 3.26B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 677.56M | 423.24M | 270.26M | 220.18M | 38.54M |
| Net Income | 59.01M | -43.19M | 14.08M | 183.36M | -157.92M |
| EPS (Diluted) | 0.75 | -0.60 | 0.20 | 2.60 | -2.30 |
| Gross Profit | 370.15M | 362.33M | 213.74M | 197.29M | 29.44M |
| Operating Income | 77.22M | -45.62M | -25.20M | 9.77M | -156.64M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 763.63M | 580.55M | 526.32M | 459.67M | 232.80M |
| Total Liabilities | 196.03M | 142.12M | 87.48M | 63.52M | 47.76M |
| Shareholders' Equity | 567.61M | 438.44M | 438.84M | 396.15M | 185.04M |
| Total Debt | 9.50M | 9.86M | 12.26M | 5.92M | 6.05M |
| Cash & Equivalents | 165.60M | 183.58M | 107.95M | 122.72M | 122.47M |
| Current Assets | 527.18M | 331.80M | 276.30M | 243.06M | 196.45M |
| Current Liabilities | 139.18M | 100.62M | 63.67M | 47.07M | 44.82M |